CLBAX
Price
$35.65
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
RLEFX
Price
$35.69
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

CLBAX vs RLEFX

Header iconCLBAX vs RLEFX Comparison
Open Charts CLBAX vs RLEFXBanner chart's image
American Funds American Balanced 529A
Price$35.65
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$35.69
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CLBAX vs RLEFX Comparison Chart
Loading...
VS
CLBAX vs. RLEFX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CLBAX (235B) and RLEFX (235B) have equal amount of cash in the bank . RLEFX pays higher dividends than CLBAX: RLEFX (2.42) vs CLBAX (2.23). CLBAX was incepted earlier than RLEFX: CLBAX (23 years) vs RLEFX (9 years). CLBAX (171.00) and RLEFX (171.00) have comparable annual turnover. CLBAX (250) and RLEFX (250) have matching initial minimum investment requirements. RLEFX (21.19) and CLBAX (20.94) have marching annual gain over last year. CLBAX (40.06) and RLEFX (38.64) have equivalent 5 years return.
CLBAXRLEFXCLBAX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD12.73712.88399%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets235B235B100%
Annual Yield % from dividends2.232.4292%
Returns for 1 year20.9421.1999%
Returns for 3 years13.8012.81108%
Returns for 5 years40.0638.64104%
Returns for 10 years63.37N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSB21.240.40
+1.92%
Mesabi Trust
CVLT148.920.65
+0.44%
Commvault Systems
ACHL0.71N/A
+0.28%
Achilles Therapeutics plc
COGT10.540.02
+0.19%
Cogent Biosciences
HAL29.10-0.20
-0.68%
Halliburton Company